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In this issue of the American Journal of Nephrology,
Nee et al. [1] demonstrate that patients who initiated dialysis while receiving care through the Military Health
System (MHS) had a superior 1-year survival than those
who initiated dialysis outside of the MHS. MHS patients
were also more likely to receive pre-end-stage renal disease (ESRD) nephrology care (defined as nephrology
care, dietary education, and use of erythropoiesis-stimulating agents [ESAs]) and have a functioning arteriovenous fistula (AVF) at the commencement of dialysis compared to non-MHS patients. AVF placement and preESRD nephrology care provided much of the survival
advantage. Pre-ESRD nephrology care of greater than
12 months’ duration had a survival impact comparable to
that of a functioning AVF. The authors concluded that
pre-ESRD nephrology care and vascular access placement led to less mortality.
The results derived from these data in some ways are
not surprising. Dialysis initiation with an AVF has long
been associated with decreased mortality for incident hemodialysis patients, and access placement has been a defining goal of pre-ESRD nephrology care. The interesting
twist is that pre-ESRD nephrology care itself, not just the
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AVF placement, was also associated with the mortality
benefit. This finding adds to the recent studies by Quinn
et al. [2] and Brown et al. [3] that propose a more nuanced
view of the optimal care of patients with chronic kidney
disease (CKD) stages 4 and 5. In these studies, patients
who underwent an ultimately non-successful AVF placement and initiated dialysis with a hemodialysis catheter
had improved mortality compared to those who had initiated dialysis with a catheter and had yet not undergone
AVF construction. These findings imply that it is not
solely the vascular access itself but also the prosecution of
pre-ESRD nephrology care for greater than 12 months
that provides an equal portion of the survival advantage
following the onset of dialysis.
The results of Quinn et al. [2] and Brown et al. [3] augment and complement the growing body of literature that
demonstrates the benefits of pre-ESRD nephrology care,
particularly in the form of an interdisciplinary CKD clinic. Pre-ESRD nephrology education using an interdisciplinary approach results in more patients beginning dialysis at home, and also leads to a greater percentage of
patients with a permanent access when in-center hemodialysis is chosen [4]. The interdisciplinary CKD clinic
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offers important benefits beyond preparation for dialysis.
It is associated with lower mortality for pre-ESRD patients [5] and has been shown to retard the progression of
kidney disease [6] compared to usual primary care.
These results raise the question of whether AVF placement, although clearly important, should be the defining
goal of pre-ESRD CKD care. They shift the focus of preESRD CKD care from a single aspect of care to a more
multifactorial approach that encompasses the management of CKD progression and its complications; education regarding options for managing advanced CKD with
dialysis, transplantation, or supportive care; dialysis modality; vascular access placement; and, ultimately, the
transition to dialysis or conservative management. Interdisciplinary CKD care may also be a venue for providing
conservative management of advanced CKD. However,
significant, patient-related cognitive dysfunction may
preclude sufficient pre-ESRD education [7].
While the inclusive mission of the interdisciplinary
CKD clinic may fulfill the needs of many patients and nephrologists, it may also ignite a spark of anxiety. How
does one define and quantify the quality of CKD care of
this scope? This is a critical question for clinical research
and for practicing nephrologists held accountable for
their patients’ clinical outcomes. AVF placement and its
use for initiation of dialysis is a clean, binary outcome that
is easy to measure and therefore accounts for one part of
interdisciplinary CKD performance. “Nephrology care”
and “interdisciplinary CKD care” are more amorphous
concepts that raise questions such as “What exactly is/are
the important part(s) of interdisciplinary CKD care?”
And, “Are they replicable?” This holistic approach is
readily apparent but difficult to quantify. Simply, it may
be better to approximate clinical reality, particularly in
this patient-centered care era. The progression of CKD is
heterogeneous, and interventions may need to be modified based on patient characteristics and patient-related
goals [4]. Quality measures will need to embrace patientcentered care.
Why is it that so many more patients in the MHS received pre-dialysis, interdisciplinary CKD care compared
to non-MHS patients? One reason is the lack of a financial
infrastructure to support interdisciplinary CKD clinics in
the United States. The interdisciplinary kidney team is
usually comprised of a nephrologist, advanced practice
provider, and a nurse. The interdisciplinary CKD clinic
composition is variable and contingent upon exigent
needs of the local, medical environment. It may include a
dietician, social worker, and/or pharmacist based on the
requirements and resources of the practice. Some larger
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clinics may have infusion rooms for intravenous iron,
kidney transplantation medications, or simple saline solutions. In a fee-based medical system, it may be difficult
to support interdisciplinary CKD team members who
cannot generate sufficient income or whose services are
non-billable.
The progression of CKD may be a slow and unpredictable process for many patients [4]. Thus, it may take several years to demonstrate a financial benefit, particularly
if a patient changes health care systems or insurance providers. A significant challenge for the interdisciplinary
clinics of any type is to delineate the cost savings that it
generates. In the past, many interdisciplinary CKD clinics
focused on anemia management, which generated revenue to support the clinical staff. As hemoglobin targets
are now lower and as ESA use has decreased, anemia
management may no longer represent a sustainable business model for most private or academic practitioners,
that is, a highly organized and effective, interdisciplinary
CKD clinic is generally not a profitable venture. In some
circumstances, an interdisciplinary CKD clinic may run
at a financial loss. In a self-contained, protocolized, and
mandated medical system such as the Veterans Association or MHS, it is likely easier to financially justify the
interdisciplinary model because the entire cost of care is
considered. Principally, the initial and recurring expenses
of the CKD clinic are offset by the downstream savings
that are realized when patients begin dialysis within the
same system or are transitioned safely to conservative
care, absent of multiple hospitalizations that were avoided by optimal outpatient CKD care. Essentially, such wellplanned systems are simply not relegated to a short-term
profit center tactics, but, instead, a long-term cost-savings
strategy. Not surprisingly, US dialysis providers are supporting interdisciplinary CKD clinics, following patients
from pre-ESRD status to dialysis within their own spheres
of influence. Better prepared patients who transition to
ESRD are hospitalized less, thereby maintaining optimal
hemodialysis chair occupancy and profitability.
A second advantage of self-contained health care systems like the MHS is a comprehensive medical record
that is shared by all providers across inpatient and outpatient settings, as discussed by Nee and his collaborators.
Despite the rapid adoption of electronic health records
and adoption of “meaningful use,” overall communication among electronic health record platforms remains
poor. This suboptimal circumstance may produce communication lapses among providers, fragmented care after hospital discharge, difficulty in arranging referrals for
specialty care such as vascular access surgery, and dietary
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education, leading to generalized failure to deliver timely,
high-quality care.
We acknowledge that interdisciplinary CKD clinics
work successfully. They are associated with slower progression of CKD, patients who are better prepared for renal replacement therapy, and improvements in mortality
rates. The data from Nee and colleagues [1] should be
used to help justify and develop effective care systems to
deliver patient-centered care for those with advanced
CKD. Nephrologists have the tools to significantly help
patients with advanced CKD, and we must determine the
optimal way to use them. Echoing Churchill, the develop-

ment of an interdisciplinary CKD clinic is “not even the
beginning of the end” of our journey toward idealized
CKD care, but perhaps, “the end of the beginning.”
End Quotation
Now this is not the end. It is not even the beginning of the end.
But it is, perhaps, the end of the beginning. – Winston Churchill
(1942).
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